Separator

Breathe Well-being raises Rs 50 Crore in Pre-series B

Separator
A investment round co-led by 3One4 Capital, Accel, and General Catalyst netted healthtech startup Breathe Well-being Rs 50 crore, according to the company's announcement. Supermorpheus and FounderBank Capital also took part in the round. According to a statement from the company, the money will be used to improve the customer experience by bolstering its teaching academy, growing the core team, and scaling up the technology platform.

Breathe Well-being offers an alternative to medicines to prevent, manage and reverse type 2 diabetes. The startup was founded in Gurgaon by Rohan Verma and Aditya Kaicker in 2020. Verma, cofounder and CEO, Breathe Well-being, said, “India is the diabetes capital of the world and we are on a mission to change that. Our aim is a diabetes mukt bharat (diabetes-free India) with the aim of reversing diabetes for one million Indians by 2025 and we are well on track to achieving that goal."

Breathe Well-being uses a personalised coach-driven, community-first approach through interactive gamification to help people with type 2 diabetes reduce HbA1c, lose weight and reduce medication dependability.

Radhika Ananth, vice president, Accel, said: “We have been impressed by how quickly Breathe Well-being is becoming a household name for type 2 diabetes and pre-diabetes reversal across tier 2 and 3 cities of India. Accel continues to back them in their vision of building a diabetes mukt bharat.”

According to the startup, its programme has a "proven outcome with over 95% participants showing an average reduction of 1.5% in their HbA1c levels, over 98% participants removing medication, and experiencing an average weight loss of 5.5 kg over the course of the programme, which is recognised by the American Diabetes Association (ADA)".

"We have observed more than 90% of participants continue their improvements beyond 24 months into the programme," said Kaicker, cofounder and COO of Breathe Well-being. This is a significant indication of how engaging our entire method is and how willing people are to actively stop taking their diabetes medications.